Suchergebnisse
UB Katalog
Artikel & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Weniger Treffer
Gefunden in
Schlagwort
- chemotherapy 5 Treffer
- medicine.drug 4 Treffer
- carboplatin 3 Treffer
- female 3 Treffer
- humans 3 Treffer
-
45 weitere Werte:
- 03 medical and health sciences 2 Treffer
- 0302 clinical medicine 2 Treffer
- 030220 oncology & carcinogenesis 2 Treffer
- antineoplastic combined chemotherapy protocols 2 Treffer
- endocrine system diseases 2 Treffer
- gemcitabine 2 Treffer
- immunology 2 Treffer
- medizin 2 Treffer
- metastatic breast cancer 2 Treffer
- middle aged 2 Treffer
- skin and connective tissue diseases 2 Treffer
- trastuzumab 2 Treffer
- trastuzumab emtansine 2 Treffer
- triple negative breast neoplasms 2 Treffer
- triple-negative breast cancer 2 Treffer
- 0301 basic medicine 1 Treffer
- 030104 developmental biology 1 Treffer
- abemaciclib 1 Treffer
- acquired immune system 1 Treffer
- adjuvant 1 Treffer
- adjuvant therapy 1 Treffer
- ado-trastuzumab emtansine 1 Treffer
- adult 1 Treffer
- aged 1 Treffer
- albumins 1 Treffer
- animals 1 Treffer
- antibodies, monoclonal, humanized 1 Treffer
- antineoplastic agents 1 Treffer
- biology 1 Treffer
- biology.protein 1 Treffer
- biomarker (medicine) 1 Treffer
- biomarkers, tumor 1 Treffer
- breast neoplasms 1 Treffer
- cancer 1 Treffer
- capecitabine 1 Treffer
- cell proliferation 1 Treffer
- chemotherapy regimen 1 Treffer
- complete response 1 Treffer
- ctla-4 1 Treffer
- ctla-4 antigen 1 Treffer
- cytotoxic t cell 1 Treffer
- deoxycytidine 1 Treffer
- disease 1 Treffer
- disease-free survival 1 Treffer
- dna 1 Treffer
Verlag
Publikation
Sprache
7 Treffer
-
In: Journal of Clinical Oncology, Jg. 39 (2021-05-20), S. 579-579Online unknownZugriff:
-
In: International journal of cancerReferences, Jg. 146 (2018-11-20), Heft 1Online unknownZugriff:
-
In: Journal of Clinical Oncology, Jg. 32 (2014-05-20), S. 11018-11018Online unknownZugriff:
-
In: Cancer Research, Jg. 81 (2021-02-15), S. OTOnline unknownZugriff:
-
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockadeIn: Science translational medicine, Jg. 7 (2015-11-27), Heft 315Online unknownZugriff:
-
In: ESMO Open, Jg. 1 (2016), S. e000043Online unknownZugriff: